Qvar Autohaler

Qvar Autohaler is a 'preventer' inhaler used to manage and control asthma symptoms daily. It contains the active ingredient beclometasone dipropionate, a corticosteroid that works by reducing inflammation and swelling in the airways. This helps to prevent asthma attacks and control symptoms like wheezing and breathlessness. It is suitable for adults and children aged 5 years and over. If you are looking for a reliable way to manage your asthma, our online service can provide a convenient consultation and discreet delivery.
Complete a short online consultation so our prescriber can confirm the treatment suits you.
The decision to supply the specific treatment and quantity requested will be based on whether our medical team are satisfied that it will be safe, appropriate, and effective.
Or 3 interest-free payments of £6.33 via Klarna
Tracked 24 Delivery3 interest-free payments via KlarnaDiscreet packaging

Qvar Treatment

Product NameQvar
Manufacturer3M Healthcare Ltd
Active IngredientBeclometasone Dipropionate
AdministrationOral Inhalation
PresentationPressurised Inhalation Solution
Available Strengths50mcg / 1Inhaler, 100mcg / 1 Inhaler
Product TypePOM — Prescription Only
Suitable for pregnancy?Consult Doctor
Use with alcoholYes (Contains trace ethanol in inhaler)
Link to Patient Information LeafletQvar PIL ↗
Authored byNabeel

Medical Content Officer

Nabeel is a co-founder, and medical content officer of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.

Medical Doctor

Dr. Talal is a GMC registered doctor and medical content reviewer at Chemist Doctor. He ensures clinical accuracy and reliability across health content.

Approved byUsman

Medical Administrative Officer

Usman is a co-founder, and medical administrative officer of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical administration and operational priorities.

Review Date: 2 Jul 2026

Next Review: 1 Jan 2027

Published on: 19 Nov 2025

Last Updated: 3 Jul 2026